{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:12:39Z","timestamp":1775286759668,"version":"3.50.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.beha.2012.07.006","type":"journal-article","created":{"date-parts":[[2012,8,19]],"date-time":"2012-08-19T16:46:56Z","timestamp":1345394816000},"page":"319-332","source":"Crossref","is-referenced-by-count":41,"title":["Venous thromboembolism associated with pregnancy and\u00a0hormonal therapy"],"prefix":"10.1016","volume":"25","author":[{"given":"Anne Flem","family":"Jacobsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Morten","family":"Sandset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2012.07.006_bib1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1055\/s-0038-1657712","article-title":"Risk factors for pregnancy associated venous thromboembolism","volume":"78","author":"McColl","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2012.07.006_bib2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0029-7844(99)00426-3","article-title":"Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy","volume":"94","author":"Gherman","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beha.2012.07.006_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0029-7844(99)00308-7","article-title":"Thrombotic risk during pregnancy: a population study","volume":"94","author":"Lindqvist","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beha.2012.07.006_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0306-5456(00)00004-8","article-title":"Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database","volume":"108","author":"Simpson","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.beha.2012.07.006_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beha.2012.07.006_bib6","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beha.2012.07.006_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ajog.2007.08.041","article-title":"Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium \u2013 a register-based case-control study","volume":"198","author":"Jacobsen","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beha.2012.07.006_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0038-1648485","article-title":"Venous thrombosis during pregnancy: leg and trimester of presentation","volume":"67","author":"Ginsberg","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2012.07.006_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/bmj.2.5543.14","article-title":"Iliac vein compression \u2013 its relation to iliofemoral thrombosis and the post-thrombotic syndrome","volume":"2","author":"Cockett","year":"1967","journal-title":"Br Med J"},{"key":"10.1016\/j.beha.2012.07.006_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1503\/cmaj.091692","article-title":"Anatomic distribution of deep vein thrombosis in pregnancy","volume":"182","author":"Chan","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.beha.2012.07.006_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-0528.2010.02847.x","article-title":"Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: 2006\u20132008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom","volume":"118","author":"Cantwell","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.beha.2012.07.006_bib12","unstructured":"Confidential enquiry into maternal and child health: saving Mothers' lives: reviewing maternal deaths to make motherhood safer \u2013 2003\u20132005. Internet communication; http:\/\/www.hqip.org.uk\/assets\/NCAPOP-Library\/CMACE-Reports\/21.-December-2007-Saving-Mothers-Lives-reviewing-maternal-deaths-to-make-motherhood-safer-2003-2005.pdf."},{"key":"10.1016\/j.beha.2012.07.006_bib13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-149-10-200811180-00004","article-title":"Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis","volume":"149","author":"Kahn","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beha.2012.07.006_bib14","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/j.1538-7836.2008.03180.x","article-title":"Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis","volume":"6","author":"Tick","year":"2008","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.beha.2012.07.006_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)61753-4","article-title":"Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial","volume":"379","author":"Enden","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2012.07.006_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.amjmed.2010.01.027","article-title":"Venous compression for prevention of postthrombotic syndrome: a meta-analysis","volume":"123","author":"Musani","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2012.07.006_bib17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1538-7836.2012.04690.x","article-title":"Prevalence and predictors for post-thrombotic syndrome three to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study","volume":"10","author":"Wik","year":"2012","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.beha.2012.07.006_bib18","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1538-7836.2011.04468.x","article-title":"Long-term quality of life after pregnancy-related deep vein thrombosis and the influence of socioeconomic factors and comorbidity","volume":"9","author":"Wik","year":"2011","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.beha.2012.07.006_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0038-1661167","article-title":"Haemostasis in normal pregnancy","volume":"52","author":"Stirling","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2012.07.006_bib20","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1055\/s-0037-1615035","article-title":"Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy","volume":"79","author":"Clark","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2012.07.006_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2141.2011.08712.x","article-title":"Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism","volume":"154","author":"Bergrem","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2012.07.006_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0037-1614518","article-title":"APC resistance and other haemostatic variables during pregnancy and puerperium","volume":"81","author":"Kjellberg","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2012.07.006_bib23","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(98)10265-9","article-title":"Thrombosis in pregnancy: maternal and fetal issues","volume":"353","author":"Greer","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2012.07.006_bib24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1538-7836.2004.01108.x","article-title":"D-dimer levels during delivery and the postpartum","volume":"3","author":"Epiney","year":"2005","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.beha.2012.07.006_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0741-5214(96)70010-1","article-title":"Anatomic and physiologic changes in lower extremity venous hemodynamics associated with pregnancy","volume":"24","author":"Cordts","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.beha.2012.07.006_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1469-0705.1996.08020093.x","article-title":"Venous circulation in the maternal lower limb: a Doppler study with the Valsalva maneuver","volume":"8","author":"Palmgren","year":"1996","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.beha.2012.07.006_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1067\/mob.2001.107919","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study","volume":"184","author":"Danilenko-Dixon","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beha.2012.07.006_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1538-7836.2005.01195.x","article-title":"ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study","volume":"3","author":"Larsen","year":"2005","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.beha.2012.07.006_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.thromres.2006.12.003","article-title":"Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study","volume":"120","author":"Larsen","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2012.07.006_bib30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1538-7836.2008.02961.x","article-title":"Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study","volume":"6","author":"Jacobsen","year":"2008","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.beha.2012.07.006_bib31","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/01.AOG.0000188387.88032.41","article-title":"Maternal outcomes in pregnancies complicated by obesity","volume":"106","author":"Robinson","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beha.2012.07.006_bib32","doi-asserted-by":"crossref","first-page":"I9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","article-title":"Risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.beha.2012.07.006_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2012.07.006_bib34","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.beha.2012.07.006_bib35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-125-12-199612150-00003","article-title":"Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis","volume":"125","author":"Friederich","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beha.2012.07.006_bib36","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinternmed.2008.589","article-title":"The value of family history as a risk indicator for venous thrombosis","volume":"169","author":"Bezemer","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beha.2012.07.006_bib37","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/j.1538-7836.2010.04038.x","article-title":"Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms","volume":"8","author":"Jacobsen","year":"2010","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.beha.2012.07.006_bib38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2141.2001.02766.x","article-title":"The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden","volume":"113","author":"Middeldorp","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2012.07.006_bib39","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1055\/s-0037-1616134","article-title":"Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia","volume":"86","author":"Martinelli","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2012.07.006_bib40","first-page":"1305","article-title":"Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women","volume":"86","author":"Tormene","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2012.07.006_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0049-3848(84)90260-3","article-title":"Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound","volume":"34","author":"Forestier","year":"1984","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2012.07.006_bib42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0038-1646558","article-title":"Risks to the fetus of anticoagulant therapy during pregnancy","volume":"61","author":"Ginsberg","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2012.07.006_bib43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.0306-5251.2001.01517.x","article-title":"Excretion of low molecular weight heparin in human milk","volume":"52","author":"Richter","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.beha.2012.07.006_bib44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2012.07.006_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.07.006_bib46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejogrb.2011.08.005","article-title":"Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile","volume":"159","author":"Nelson-Piercy","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.beha.2012.07.006_bib47","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0037-1612970","article-title":"Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin","volume":"87","author":"Pettila","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2012.07.006_bib48","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1538-7836.2007.02634.x","article-title":"Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial","volume":"5","author":"Rodger","year":"2007","journal-title":"J Thromb Haemostasis"},{"issue":"Suppl. A","key":"10.1016\/j.beha.2012.07.006_bib49","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S1550-8579(05)80060-9","article-title":"Venous thromboembolism and anticoagulant therapy in pregnancy","volume":"2","author":"Greer","year":"2005","journal-title":"Gend Med"},{"key":"10.1016\/j.beha.2012.07.006_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1160\/TH04-06-0345","article-title":"Treatment of 51 pregnancies with danaparoid because of heparin intolerance","volume":"93","author":"Lindhoff-Last","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2012.07.006_bib51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.thromres.2011.10.037","article-title":"Fondaparinux \u2013 data on efficacy and safety in special situations","volume":"129","author":"Nagler","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2012.07.006_bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11239-006-5709-z","article-title":"Thrombolytic therapy in pregnancy","volume":"21","author":"Leonhardt","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.beha.2012.07.006_bib53","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1016\/j.thromres.2010.05.005","article-title":"Prophylaxis against prosthetic mitral valve thrombosis with unfractionated heparin administered by an elastometric infusion pump","volume":"126","author":"Sandset","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2012.07.006_bib54","doi-asserted-by":"crossref","first-page":"e1S","DOI":"10.1378\/chest.11-2290","article-title":"Patient values and preferences in decision making for antithrombotic therapy: a systematic review: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"MacLean","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.beha.2012.07.006_bib55","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2002-01-0149","article-title":"Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism","volume":"100","author":"Pabinger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.07.006_bib56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9378(89)90095-1","article-title":"Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis?","volume":"160","author":"Tengborn","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beha.2012.07.006_bib57","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","article-title":"Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis","volume":"3","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.beha.2012.07.006_bib58","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2006.06317.x","article-title":"The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis","volume":"135","author":"de Stefano","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2012.07.006_bib59","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of clot in this Pregnancy Study Group","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2012.07.006_bib60","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1378\/chest.11-2288","article-title":"Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.beha.2012.07.006_bib61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.295.2.199","article-title":"Does this patient have deep vein thrombosis?","volume":"295","author":"Wells","year":"2006","journal-title":"J Am Med Assoc"},{"issue":"Suppl. 3","key":"10.1016\/j.beha.2012.07.006_bib62","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0049-3848(11)70005-6","article-title":"The diagnostic management of acute venous thromboembolism during pregnancy: recent advancements and unresolved issues","volume":"127","author":"Tan","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2012.07.006_bib63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.316.7124.17","article-title":"Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study","volume":"316","author":"Cogo","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.beha.2012.07.006_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-151-2-200907210-00004","article-title":"Predicting deep venous thrombosis in pregnancy: out in \"LEFt\" field?","volume":"151","author":"Chan","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beha.2012.07.006_bib65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0049-3848(02)00105-6","article-title":"Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy","volume":"107","author":"Chan","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2012.07.006_bib66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-144-3-200602070-00003","article-title":"Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism","volume":"144","author":"Roy","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beha.2012.07.006_bib67","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(08)60594-2","article-title":"Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial","volume":"371","author":"Righini","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2012.07.006_bib68","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.298.23.2743","article-title":"Computed tomographic pulmonary angiography vs ventilation\u2013perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial","volume":"298","author":"Anderson","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.beha.2012.07.006_bib69","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.2214\/AJR.09.3506","article-title":"Pulmonary embolism in pregnancy: CT pulmonary angiography versus perfusion scanning","volume":"195","author":"Shahir","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.beha.2012.07.006_bib70","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1538-7836.2005.01779.x","article-title":"Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review","volume":"4","author":"Nijkeuter","year":"2006","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.beha.2012.07.006_bib71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1471-0528.2003.02182.x","article-title":"Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy","volume":"110","author":"Jacobsen","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.beha.2012.07.006_bib72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0049-3848(99)00228-5","article-title":"Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients. A prospective cohort study","volume":"98","author":"Crowther","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2012.07.006_bib73","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1471-0528.2002.01525.x","article-title":"Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series","volume":"109","author":"Rodie","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.beha.2012.07.006_bib74","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0002-9378(03)00953-0","article-title":"Tinzaparin sodium for thrombosis treatment and prevention during pregnancy","volume":"190","author":"Smith","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beha.2012.07.006_bib75","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2012.07.006_bib76","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.beha.2012.07.006_bib77","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hq0202.102318","article-title":"Female hormones and thrombosis","volume":"22","author":"Rosendaal","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.beha.2012.07.006_bib78","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2010.04148.x","article-title":"Hormone therapies and venous thromboembolism: where are we now?","volume":"9","author":"van Hylckama Vlieg","year":"2011","journal-title":"J Thromb Haemostasis"},{"issue":"Suppl. 2","key":"10.1016\/j.beha.2012.07.006_bib79","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0049-3848(09)70015-5","article-title":"Mechanisms of thrombosis related to hormone therapy","volume":"123","author":"Sandset","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2012.07.006_bib80","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen-induced venous thromboembolism","volume":"126","author":"Tchaikovski","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2012.07.006_bib81","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.beha.2012.07.006_bib82","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.beha.2012.07.006_bib83","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.beha.2012.07.006_bib84","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.beha.2012.07.006_bib85","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1055\/s-0037-1614156","article-title":"Increased risk of recurrent venous thromboembolism during hormone replacement therapy \u2013 results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)","volume":"84","author":"Hoibraaten","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2012.07.006_bib86","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2012.07.006_bib87","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.ATV.0000018301.91721.94","article-title":"Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease","volume":"22","author":"Herrington","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.beha.2012.07.006_bib88","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1538-7836.2003.t01-2-00177.x","article-title":"Etonogestrel implant use is not related to hypercoagulable changes in anticoagulant system","volume":"1","author":"Lindqvist","year":"2003","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.beha.2012.07.006_bib89","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2007.03.003","article-title":"Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"76","author":"Jick","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.beha.2012.07.006_bib90","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.contraception.2009.12.009","article-title":"Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users","volume":"81","author":"Dore","year":"2010","journal-title":"Contraception"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692612000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692612000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T18:12:27Z","timestamp":1594577547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692612000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1521692612000631"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2012.07.006","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}